Navigating the Future: The Booming NSCLC Treatment Market in 2024
Lung cancer remains one of the most formidable health challenges globally, with Non-Small Cell Lung Cancer (NSCLC) accounting for approximately 85% of all lung cancer cases. In 2023, the NSCLC treatment market was valued at a staggering USD 19.38 billion, and it’s poised for exponential growth, expected to reach nearly USD 45.70 billion by 2032. … Read more